IMPACT
PH significantly impacts patients with ILD1,2
PH in patients with ILD is associated with:
PH is an increase in mean pulmonary arterial pressure (mPAP)2
Even mild increases in mPAP can impact patients with ILD (eg, IPF)3
About half of patients with both IPF and PH have slightly elevated mPAP of 25-30 mm Hg2
6MWT=6-minute walk test; CPET=cardiopulmonary exercise testing; ILD=interstitial lung disease; IPF=idiopathic pulmonary fibrosis; PH=pulmonary hypertension.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.